Preparing stock dashboard...

Daewon Pharmaceutical Co., Ltd.

003220.KS - KSE

Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis use. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 40 countries primarily in Asia, Central and South America, the Middle East, CIS, and Africa. The company was founded in 1958 and is headquartered in Seoul, South Korea.

Daewon Pharmaceutical Co., Ltd. trades as 003220.KS on KSE. Its latest stored price is $10,540.00 as of June 9, 2026.

Data updated June 9, 2026

Price
$10,540.00

Financial Snapshot

Metric Value ('000,000)

Stock Analysis

Scores this stock using the same metrics model as the compare page.

Metric Value Score

Price Chart

Mouse wheel or pinch to zoom. Drag chart to pan. Double-click to reset zoom.